Healthcare, especially Biotechnology, leads with numerous strong buy ratings across the past three days, including AUPH, KYMR, and ARWR. Technology also sees momentum with quantum computing names IONQ and QBTS initiating strong buys, alongside large-cap upgrades for ECL, STX, and MELI. However, recent mega-cap downgrades for NVO, BKNG, and CSCO suggest a cautious sentiment shift in some established sectors.
Disclaimer: This article is for informational purposes only and does not constitute financial advice. We are not financial professionals. The authors and/or site operators may hold positions in the companies or assets mentioned. Always do your own research before making financial decisions.
Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications.